<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(5)</volume><submitter>Zheng C</submitter><funding>Intramural NIH HHS</funding><pubmed_abstract>The promoter is a major element in the expression cassette of gene therapy vectors. Optimal promoter selection can enhance target specificity and gene expression. Recently, we evaluated three different human elongation factor 1 alpha (EF1α) promoters. The three promoters were put into the same expression vector, pAC-luc, driving expression of the luciferase cDNA. The activity from one EF1α promoter (termed EF1α -3), obtained in a commercial vector, was markedly lower when tested in vitro (from 50 - 500 x) in four cell lines and in vivo in rat submandibular glands (~250 x). Sequence differences in the EF1α -3 promoter likely account for the activity differences seen. Investigators need to recognize that all promoters of the same name may not be equivalent in driving transgene expression.</pubmed_abstract><journal>International journal of medical sciences</journal><pagination>404-8</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3970091</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>All human EF1α promoters are not equal: markedly affect gene expression in constructs from different sources.</pubmed_title><pmcid>PMC3970091</pmcid><pubmed_authors>Baum BJ</pubmed_authors><pubmed_authors>Zheng C</pubmed_authors></additional><is_claimable>false</is_claimable><name>All human EF1α promoters are not equal: markedly affect gene expression in constructs from different sources.</name><description>The promoter is a major element in the expression cassette of gene therapy vectors. Optimal promoter selection can enhance target specificity and gene expression. Recently, we evaluated three different human elongation factor 1 alpha (EF1α) promoters. The three promoters were put into the same expression vector, pAC-luc, driving expression of the luciferase cDNA. The activity from one EF1α promoter (termed EF1α -3), obtained in a commercial vector, was markedly lower when tested in vitro (from 50 - 500 x) in four cell lines and in vivo in rat submandibular glands (~250 x). Sequence differences in the EF1α -3 promoter likely account for the activity differences seen. Investigators need to recognize that all promoters of the same name may not be equivalent in driving transgene expression.</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014</publication><modification>2025-04-22T01:01:17.432Z</modification><creation>2019-03-27T01:24:11Z</creation></dates><accession>S-EPMC3970091</accession><cross_references><pubmed>24688302</pubmed><doi>10.7150/ijms.8033</doi></cross_references></HashMap>